1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Switzerland: WHO Press; 2017.
2. O’Brien S, Radich JP, Abboud CN, Akhtari M, Altman JK, Berman E, et al. Chronic myelogenous leukemia, version 1.2015. J Natl Compr Cancer Netw. 2014;12(11):1590–610.
3. Pane F, Frigeri F, Sindona M, Luciano L, Ferrara F, Cimino R, et al. Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction). Blood. 1996;88(7):2410–4.
4. Cervantes F, Urbano-Ispizua A, Villamor N, Feliu E, Milla F, Lopez-Guillermo A, et al. Ph-positive chronic myeloid leukemia mimicking essential thrombocythemia and terminating into megakaryoblastic blast crisis: report of two cases with molecular studies. Leukemia. 1993;7(2):327–30.
5. Parilla M, Venkataraman G. The thin line between CML and CMML. Blood. 2017;129(17):2456.